Complement activation during and after open-heart surgery is only marginally affected by the choice of fluid for volume replacement

Perfusion

Volumn 11, Issue 4, 1996, Pages 326-332

  Svennevig, J L ^a,b   Tollofsrud S ^a   Kongsgaard, U ^a   Noddeland, H ^a   Mohr, B ^a   Ozer M ^a   Mollnes, T E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN 70; POLYGELINE; RINGER ACETATE;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CORONARY ARTERY SURGERY; FEMALE; HEMODILUTION; HUMAN; INDUCED HYPOTHERMIA; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL;

EID: 0029766194     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919601100405     Document Type: Article

References (22)

1. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a analphylatoxins. N Engl J Med 1981; 304: 497-503.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
3. Fosse E, Mollnes TE, Ingvaldsen B. Complement activation during major operations with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 806-66.
4. Nilsson L, Brunnkvist S, Nilsson U et al. Activation of inflammatory system during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1988; 22: 51-53.
5. Videm V, Fosse E, Mollnes TE, Karlsen H, Pedersen T, Garred P. Complement activation induced by different tubings used for cardiopulmonary bypass. J Extracorpor Tech 1989; 21: 20-33.
6. Mellbye OJ, Frøland SS, Lilleaasen P, Svennevig JL, Mollnes TE. Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. Eur Surg Res 1988; 20: 101-109.
7. Bonser RS, Dave JR, Davies ET et al. Reduction of complement activation during bypass by prime manipulation. Ann Thorac Surg 1990; 49: 279-83.
8. Videm V, Mollnes TE. Human complement activation by polygeline and dextran 70. Scand J Immunol 1994; 39: 314-20.
9. Videm V, Fosse E, Mollnes TE, Garred P. Complement activation by extracorporeal circulation: effects of precoating a membrane oxygenator circuit with human whole blood. Scand J Thorac Cardiovasc Surg 1988; 22: 251-56.
10. Videm V, Svennevig JL, Fosse E, Semb G, Østerud A, Mollnes TE. Reduced complement activation with heparin coated oxygenators and tubings in coronary bypass surgery. J Thorac Cardiovasc Surg 1992; 103: 806-13.
11. Garred P, Mollnes TE, Lea T. Quantification in ELISA of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988; 27: 329-35.
12. Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against neoantigen on the complex. Scand J Immunol 1985; 22: 197-202.
13. Laks H, Standeven J, Blair O, Hahn J, Jellinek M, Willman VL. The effects of cardiopulmonary bypass with crystalloid and colloid hemodilution on myocardial extravascular water. J Thorac Cardiovasc Surg 1977; 73: 129-37.
14. Karenko MS, Klossner JA, Laaksonen VO. Restoration of volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 1987; 15: 559-66.
15. Ley SJ, Miller K, Skov P, Preisig P. Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 1990; 19: 31-40.
16. Tamiya T, Yamasaki M, Maeo Y, Yamashiro T, Ogoshi S, Fujimoto S. Complement activation during cardiopulmonary bypass: attenuation by hypothermia, heparin, and hemodilution. Ann Surg 1988; 208: 95-193.
17. van Oeveren W, Kazatchkene MD, Descamps-Latscha B et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888-99.
18. Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL. Complement activation with bubble and membrane oxygenators in aortocoronary bypass surgery. Ann Thorac Surg 1990; 50: 387-91.
19. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjørnskau L. Duration of cardiopulmonary bypass compared with changes in the plasma protease systems. Scand J Thorac Cardiovasc Surg 1991; 25: 223-26.
20. Schøtt U, Berseus O, Jaremo P. Blood substitution and complement activation. Acta Anaesthesiol Scand 1987; 31: 559-66.
21. Moore FD, Warner KG, Assousa S, Valeri CR, Khuri SF. The effects of complement activation during cardiopulmonary bypass: attenuation by hypothermia, heparin, and hemodilution. Ann Surg 1988; 208: 95-103.
22. Mickleborough LL, Arnold G, Chiu RC. Complement consumption during cardiopulmonary bypass: bubble versus membrane oxygenators. Perfusion 1986; 1: 261-69.